La Gro's practice has vast experience in assisting with the corporate restructuring of healthcare entities and UPC infringement proceedings. Practice head Marleen van den Horst is well known for handling SPC and regulatory issues, and often acts for large pharmaceutical companies in matters concerning clinical trials and orphan medicinal products. Benjamin Niemeijer has expertise in IP litigation, and often assists healthcare providers with tech-related transfers.
Legal 500 Editorial commentary
- Profile
Testimonials
Collated independently by Legal 500 research team.
‘The team are very knowledgeable and great to work with. Very reliable.’
‘Pleasant personal attention, capable of providing timely suitable solutions.’
‘Benjamin Niemeijer is knowledgeable and truly cares for his clientele, and is able to provide the correct input needed to make good decisions and to make the process seamless.’
Key clients
- Stichting Alrijne Zorggroep
- Insud Pharma
- Leiden University Medical Center
- Move the Brain
- Oldelft Ultrasound
- Stada Arzneimittel
- Adalvo
- Focus Care Pharmaceuticals
- Amgen
- OrthoApnea
Work highlights
- Represented Amgen in biosimilar patent litigation.
- Represented Insud Pharma in invalidity proceedings concerning pharmaceutical patents.
- Representing OrthoApnea and Vivisol B in patent infringement proceedings.
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Marleen van den Horst
Other key lawyers
Benjamin Niemeijer; Iris Arts